ADDITIONAL INFORMATION BOARD AND COMMITTEE ATTENDANCE The table below shows the number of Board and Committee meetings each Director was eligible to attend and attended during the financial year ended 31 December 2023: Board Audit and Risk Remuneration Director Held (i) Attended Held (i) Attended Held (i) Attended Patrick Davies 11 11 2 2 1 1 Dr Trevor Scott 11 11 2 2 1 1 Dianne Angus 11 11 2 2 1 1 Dr Jenny Harry 11 11 2 2 1 1 Jonathan Pilcher 11 11 – – – – Joe Basile 9 9 1 1 1 1 (i) Number of meetings held during the time the Director was a member of the Board or Committee INTERESTS REGISTER The Company is required to maintain an interests register in which particulars of certain transactions and matters involving Directors must be recorded. Details of the entries in this register for each of the Directors during and since the end of 2023 are as follows: Director Ordinary Shares Purchased/(Sold) Consideration Paid/(Received) Date of Transaction Trevor Scott (1,175,000) ($15,275,000) 14 June 2023 Joe Basile 5,000 $59,950 13 September 2023 INFORMATION USED BY DIRECTORS During the year the Board received no notices from Directors of the Company requesting to use Company information received in their capacity as Directors, which would not otherwise have been available to them. INDEMNIFICATION AND INSURANCE OF DIRECTORS AND OFFICERS Neuren has entered into a deed of indemnity, insurance and access with Directors and Officers, which provides that Directors and Officers generally will incur no monetary loss as a result of actions undertaken by them as Directors and Officers. The indemnity does not cover criminal liability or liability in respect of a breach of a director’s duty to act in good faith and in what the director believes to be the best interests of the Company or a breach of any fiduciary duty owed to the Company or a subsidiary. DONATIONS No donations were made by the Company or its subsidiary companies during the year (2022: $nil). Neuren Pharmaceuticals Limited Annual Report 2023 53
RkJQdWJsaXNoZXIy MjE2NDg3